CLOV logo

Clover Health Investments, Corp. (CLOV)

Profile

Full Name

Clover Health Investments, Corp.

Ticker

NASDAQ: CLOV

Exchange

NASDAQ

Sector

Healthcare

Industry

Healthcare Plans

Country

United States

IPO

June 12, 2020

Indexes

Not included

Website

http://www.cloverhealth.com

Employees

570

Key Details

Price

$3.11(+5.78%)

Market cap

Last Dividend

$0.10

TTM Dividend yield

-

Annual revenue

$1.37B(+8.77% YoY)

Annual EPS

-$0.08(+82.22% YoY)

PE ratio

-

Next earnings date

Aug 5, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $3.11
    CLOV price is $3.11

    30-Day Relative Volume

    1.12
    CLOV 30-day relative volume is 1.12

    Price Performance

    Price Most recent change

    +5.78%
    CLOV price was up +5.78% on Jul 21, 2025

    Price YTD change

    -1.27%
    CLOV price is down -1.27% since January 1st

    Price 1-year change

    +85.12%
    CLOV price is up +85.12% year-on-year

    Price 3-year change

    +17.36%
    CLOV price is up +17.36% over the past 3 years

    Price Range

    Price All-time high

    $28.85
    CLOV price is currently -89.22% below its historical high of $28.85

    Price 3-year low

    $0.61
    CLOV price is currently +413.20% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.58B
    CLOV market capitalization is $1.58 billion

    Market cap 3-year change

    +25.11%
    CLOV market capitalization is up +25.11% over the past 3 years

    Market cap All-time high

    $9.04B
    CLOV market capitalization is currently -82.49% below its historical high of $9.04 billion

    Market cap sector rank

    79.92%
    CLOV market capitalization is higher than 79.92% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +2.58%
    CLOV shares outstanding is up +2.58% year-on-year

    Shares Outstanding 3-Year Change

    +6.6%
    CLOV shares outstanding is up +6.6% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.83
    CLOV beta is 0.83

    200-day SMA

    $3.57
    CLOV price is currently -12.95% below its 200-day simple moving average

    50-day SMA

    $3.08
    CLOV price is currently +0.97% above its 50-day simple moving average

    RSI

    55.95
    CLOV 14-day relative strength index is 55.95

    Volume

    1.12
    CLOV 30-day relative volume is 1.12

    ATR

    $0.18
    CLOV average true range is $0.18

    10-day Historical Volatility

    58.21%
    CLOV 10-day historical volatility is 58.21%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $0.10
    CLOV last dividend was $0.10 per share, with an ex-dividend date of August 23, 2021

    Next Dividend

    -
    CLOV next dividend has not yet been announced

    Dividend per share

    Dividend per share

    -
    CLOV annual dividend per share value is unknown

    Dividend per share Sector Rank

    -
    CLOV annual dividend per share is unknown

    Dividend per share 1-Year Change

    -
    CLOV annual dividend per share 1-year change is unknown

    Dividend per share 3-Year Change

    -
    CLOV annual dividend per share 3-year change is unknown

    Dividend yield

    Dividend yield

    -
    CLOV annual dividend yield value is unknown

    Dividend yield Sector Rank

    -
    CLOV annual dividend yield is unknown

    Other

    Payout ratio

    -
    CLOV annual payout ratio value is unknown

    Dividends paid

    -
    CLOV annual dividends paid value is unknown

    Free cash flow

    $33.29M
    CLOV annual free cash flow is $33.29 million

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $1.37B
    CLOV annual revenue is $1.37 billion

    Revenue Analysts estimate

    $1.86B
    CLOV annual revenue is currently -26.38% lower than the consensus analysts' forecast

    Revenue 1-year change

    +8.77%
    CLOV annual revenue is up +8.77% year-on-year

    Revenue Sector rank

    82.88%
    CLOV annual revenue is higher than 82.88% of companies in Healthcare sector

    EPS

    EPS

    -$0.08
    CLOV annual earnings per share is -$0.08

    EPS Analysts estimate

    $0.11
    CLOV annual earnings per share is currently -172.73% lower than the consensus analysts' forecast

    EPS 1-year change

    +82.22%
    CLOV annual earnings per share is up +82.22% year-on-year

    EPS Sector rank

    79.7%
    CLOV annual earnings per share is higher than 79.7% of companies in Healthcare sector

    Profit

    Gross profit

    $364.80M
    CLOV annual gross profit is $364.80 million

    Gross margin

    26.61%
    CLOV annual gross profit margin is 26.61%

    Operating profit

    -$45.46M
    CLOV annual operating income is -$45.46 million

    Operating margin

    -3.32%
    CLOV annual operating profit margin is -3.32%

    Net income

    -$43.01M
    CLOV annual net profit is -$43.01 million

    Net margin

    -3.14%
    CLOV annual net profit margin is -3.14%

    Expenses

    Total expenses

    $1.42B
    CLOV annual total expenses is $1.42 billion

    Operating expenses

    $410.26M
    CLOV annual total operating expenses is $410.26 million

    Cost of goods sold

    $1.01B
    CLOV annual cost of goods sold is $1.01 billion

    Selling, general & administrative expenses

    $408.93M
    CLOV annual SGA is $408.93 million

    Depreciation and amortization

    $1.33M
    CLOV annual depreciation & amortization is $1.33 million

    Interest expense

    $0.00
    CLOV annual interest expense is $0.00

    Income tax

    -
    CLOV annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$46.27M
    CLOV annual earnings before interest & taxes is -$46.27 million

    EBITDA

    -$44.94M
    CLOV annual EBITDA is -$44.94 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $580.74M
    CLOV annual total assets is $580.74 million

    Non current assets

    $237.62M
    CLOV annual long term assets is $237.62 million

    Current assets

    $343.12M
    CLOV annual total current assets is $343.12 million

    Cash and cash equivalents

    $194.54M
    CLOV annual cash & cash equivalents is $194.54 million

    Accounts receivable

    -
    CLOV annual accounts receivable value is unknown

    Inventory

    -
    CLOV annual inventory value is unknown

    Liabilities

    Total liabilities

    $239.60M
    CLOV annual total liabilities is $239.60 million

    Long term liabilities

    $26.08M
    CLOV annual total long term liabilities is $26.08 million

    Current liabilities

    $213.52M
    CLOV annual total current liabilities is $213.52 million

    Accounts payable

    $34.56M
    CLOV annual accounts payable is $34.56 million

    Debt

    Total debt

    $0.00
    CLOV annual total debt is $0.00

    Total debt 1-year change

    0%
    CLOV annual total debt has remained unchanged year-on-year

    Long term debt

    -
    CLOV annual long term debt value is unknown

    Short term debt

    -
    CLOV annual short term debt value is unknown

    Equity & Capital

    Shareholders equity

    $341.14M
    CLOV annual stockholders equity is $341.14 million

    Book value

    $341.14M
    CLOV annual book value is $341.14 million

    Retained earnings

    -$2.20B
    CLOV annual retained earnings is -$2.20 billion

    Working capital

    $129.61M
    CLOV annual working capital is $129.61 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $34.84M
    CLOV annual cash flow from operations is $34.84 million

    Cash from operations 1-year change

    +124.09%
    CLOV annual cash flow from operations is up +124.09% year-on-year

    Cash from investing

    $565.00K
    CLOV annual cash flow from investing activities is $565.00 thousand

    Cash from investing 1-year change

    -99.6%
    CLOV annual cash flow from investing activities is down -99.6% year-on-year

    Cash from financing

    -$17.36M
    CLOV annual cash flow from financing activities is -$17.36 million

    Cash from financing 1-year change

    -242.43%
    CLOV annual cash flow from financing activities is down -242.43% year-on-year

    CAPEX

    CAPEX

    $1.56M
    CLOV annual capital expenditures is $1.56 million

    CAPEX 1-year change

    +166.44%
    CLOV annual capital expenditures is up +166.44% year-on-year

    Free Cash Flow

    Free cash flow

    $33.29M
    CLOV annual free cash flow is $33.29 million

    Free cash flow 1-year change

    +122.92%
    CLOV annual free cash flow is up +122.92% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    26.61%
    CLOV annual gross profit margin is 26.61%

    Operating margin

    -3.32%
    CLOV annual operating profit margin is -3.32%

    Net margin

    -3.14%
    CLOV annual net profit margin is -3.14%

    ROA & ROE

    ROA

    -7.47%
    CLOV annual return on assets is -7.47%

    ROE

    -13.71%
    CLOV annual return on equity is -13.71%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    CLOV price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    CLOV price to earnings ratio is unknown

    PB Ratio

    PB ratio

    4.71
    CLOV price to book ratio is 4.71

    PB ratio Sector rank

    77.97%
    CLOV price to book ratio is higher than 77.97% of companies in Healthcare sector

    PS Ratio

    PS ratio

    1.06
    CLOV price to sales ratio is 1.06

    PS ratio Sector rank

    24.9%
    CLOV price to sales ratio is higher than 24.9% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $1.43B
    CLOV enterprise value is $1.43 billion

    Enterprise value Sector rank

    77.31%
    CLOV enterprise value is higher than 77.31% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -62.35
    CLOV EV/EBITDA is -62.35

    EV/EBITDA Sector rank

    3.16%
    CLOV EV/EBITDA is higher than 3.16% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.61
    CLOV annual current ratio is 1.61

    Quick ratio

    -
    CLOV annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.00
    CLOV annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    CLOV annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    CLOV piotroski f-score value is unknown

    Altman Z-Score

    1.02
    CLOV altman z-score is 1.02

    Analyst ratings

    Recent major analysts updates

    Mar 3, 25 Canaccord Genuity
    Buy
    Dec 17, 24 Craig-Hallum
    Buy
    Oct 7, 24 UBS
    Neutral
    Aug 11, 23 Citigroup
    Neutral
    Mar 6, 23 Credit Suisse
    Underperform
    Mar 6, 23 Canaccord Genuity
    Buy
    Nov 16, 22 Citigroup
    Neutral
    Nov 8, 22 SVB Leerink
    Market Perform
    Aug 9, 22 Credit Suisse
    Underperform
    Aug 9, 22 Citigroup
    Neutral

    Institutional Ownership

    Screeners with CLOV included

    Growing Shares Outstanding
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biggest stock gainers today
    • What is the ticker symbol for Clover Health Investments, Corp.?
    • Does Clover Health Investments, Corp. pay dividends?
    • What sector is Clover Health Investments, Corp. in?
    • What industry is Clover Health Investments, Corp. in?
    • What country is Clover Health Investments, Corp. based in?
    • When did Clover Health Investments, Corp. go public?
    • Is Clover Health Investments, Corp. in the S&P 500?
    • Is Clover Health Investments, Corp. in the NASDAQ 100?
    • Is Clover Health Investments, Corp. in the Dow Jones?
    • When was Clover Health Investments, Corp.'s last earnings report?
    • When does Clover Health Investments, Corp. report earnings?

    What is the ticker symbol for Clover Health Investments, Corp.?

    The ticker symbol for Clover Health Investments, Corp. is NASDAQ:CLOV

    Does Clover Health Investments, Corp. pay dividends?

    No, Clover Health Investments, Corp. does not pay dividends

    What sector is Clover Health Investments, Corp. in?

    Clover Health Investments, Corp. is in the Healthcare sector

    What industry is Clover Health Investments, Corp. in?

    Clover Health Investments, Corp. is in the Healthcare Plans industry

    What country is Clover Health Investments, Corp. based in?

    Clover Health Investments, Corp. is headquartered in United States

    When did Clover Health Investments, Corp. go public?

    Clover Health Investments, Corp.'s initial public offering (IPO) was on June 12, 2020

    Is Clover Health Investments, Corp. in the S&P 500?

    No, Clover Health Investments, Corp. is not included in the S&P 500 index

    Is Clover Health Investments, Corp. in the NASDAQ 100?

    No, Clover Health Investments, Corp. is not included in the NASDAQ 100 index

    Is Clover Health Investments, Corp. in the Dow Jones?

    No, Clover Health Investments, Corp. is not included in the Dow Jones index

    When was Clover Health Investments, Corp.'s last earnings report?

    Clover Health Investments, Corp.'s most recent earnings report was on May 6, 2025

    When does Clover Health Investments, Corp. report earnings?

    The next expected earnings date for Clover Health Investments, Corp. is August 5, 2025
    On this page